...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
【24h】

Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.

机译:局部复发性直肠癌手术治疗后的预后和预测因素:单一机构的经验。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: Resection of locally recurrent rectal cancer (LRRC) after curative resection represents a difficult problem and a surgical challenge. The aim of this study was to evaluate the results of resecting the local recurrence of rectal cancer and to analyze factors that might predict curative resection and those that affect survival. PATIENTS AND METHODS: A retrospective review was performed in 50 patients who underwent surgical exploration with intent to cure LRRC between April 1998 and April 2005. All of the patients had previously undergone resection of primary rectal adenocarcinoma. Of these patients' charts, operation and pathology reports were reviewed. Primary tumor and treatment details, hospital of initial treatment and TNM stage were registered. The following data were collected concerning the detection of the local recurrence; date of recurrence, symptoms at the time of presentation and diagnostic work-up. Perioperative complication and date of discharge were also gathered. The recurrent tumors were classified as not fixed (F0), fixed at one site (F1) and fixed to two or more sites (F2) according to the preoperative and peroperative findings. Microscopic involvement of surgical margins and localization of recurrence were noted based on pathology reports. RESULTS: The median time interval between resection of primary tumor and surgery for locally recurrent disease was 24 (4-113) months. In a statistical analysis, initial surgery, complaints of patients, increasing number of sites of the recurrent tumor fixation in the pelvis, location of the recurrent tumor were associated with curative surgery. Curative, negative resection margins were obtained in 24 (48%) of patients; in these patients a median survival of 28 months was achieved, compared to 12 months (p=0.01) in patients with either microscopic or gross residual disease. Primary operation and CEA level at recurrence were also found to be important factors associated with improved survival. There was no operative mortality and, the complication rate was 24%. CONCLUSIONS: This study demonstrated that many patients with LRRC can be resected with negative margins. The type of primary surgery, symptoms, location, and fixity of recurrent tumor are associated with the increased possibility of carrying out curative resection. Previous surgery and curative surgery are significant predictors of both disease-specific survival and overall survival.
机译:目的:根治性切除后切除局部复发性直肠癌(LRRC)是一个难题,也是一项外科手术挑战。这项研究的目的是评估切除直肠癌局部复发的结果,并分析可能预测治愈性切除的因素以及影响生存的因素。病人和方法:回顾性回顾了50例在1998年4月至2005年4月之间接受外科手术治疗以治愈LRRC的患者。所有患者先前都接受了原发性直肠腺癌的切除术。在这些患者的图表中,回顾了手术和病理报告。登记了原发肿瘤和治疗细节,初始治疗的医院和TNM分期。收集了以下有关局部复发检测的数据;复发日期,出现时的症状和诊断性检查。还收集了围手术期并发症和出院日期。根据术前和术中发现,复发性肿瘤分为未固定(F0),固定在一个部位(F1)和固定在两个或多个部位(F2)。根据病理报告,发现手术切缘的微观累及和复发部位。结果:原发肿瘤切除与局部复发性疾病手术之间的中位时间间隔为24(4-113)个月。在统计分析中,最初的手术,患者的主诉,骨盆中复发性肿瘤固定部位的增加,复发性肿瘤的位置与治愈性手术有关。 24例(48%)患者获得治愈,阴性切除切缘;在这些患者中,中位生存期为28个月,而在显微镜下或严重残留疾病患者中,中位生存期为12个月(p = 0.01)。还发现初次手术和复发时的CEA水平是与生存率提高相关的重要因素。无手术死亡,并发症发生率为24%。结论:这项研究表明,许多LRRC患者可以切除阴性切缘。原发手术的类型,症状,位置和复发性肿瘤的固定性与进行根治性切除术的可能性增加相关。既往手术和根治性手术是疾病特异性生存期和总体生存期的重要预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号